Trial · NCT01330290
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Score of the Caregivers' Rating of Neupro® Compared to Oral Anti-Parkinson Medication | Neupro® Treatment | 1.32 | Standard Deviation 0.67 | units on a scale | |
| Mean Score of the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication | Neupro® Treatment | 1.46 | Standard Deviation 0.32 | units on a scale | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Substance in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Applicable | 89 | participants | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Substance in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Not applicable | 57 | participants | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Substance in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Missing | 1 | participants | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Application Form in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Applicable | 139 | participants | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Application Form in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Not applicable | 7 | participants | |
| Assessment of the Physicians' Rationale for the Choice of Neupro® Due to Application Form in Idiopathic Parkinsons Disease Patients Requiring Caregiver Support | Neupro® Treatment | Missing | 1 | participants | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Dysphagia in Patients With Dysphagia | Neupro® Treatment | 1.59 | Standard Deviation 0.82 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Nausea and/or Vomiting in Patients With Nausea and/or Vomiting. | Neupro® Treatment | 1.48 | Standard Deviation 0.54 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Control of Compliance | Neupro® Treatment | 1.36 | Standard Deviation 0.59 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Multiple Medication in Patients With Multiple Medication | Neupro® Treatment | 1.48 | Standard Deviation 0.60 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Surgery Requiring General Anaesthesia | Neupro® Treatment | 1.87 | Standard Deviation 0.32 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Dose Adaption | Neupro® Treatment | 1.35 | Standard Deviation 0.75 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication With Regard to Independency of Food Administration | Neupro® Treatment | 1.50 | Standard Deviation 0.44 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication With Regard to Sleeping Patients | Neupro® Treatment | 1.37 | Standard Deviation 0.58 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Risk of Interaction With Other Treatments | Neupro® Treatment | 1.15 | Standard Deviation 0.63 | units on a scale | |
| Score for the Physicians' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Resorption | Neupro® Treatment | 1.64 | Standard Deviation 0.55 | units on a scale | |
| Score for the Caregivers' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Dysphagia in Patients With Dysphagia | Neupro® Treatment | 1.44 | Standard Deviation 0.94 | units on a scale | |
| Score for the Caregivers' Rating of Neupro® Compared to Oral Anti-Parkinson Medication in Relation to Nausea and/or Vomiting in Patients With Nausea and/or Vomiting | Neupro® Treatment | 1.50 | Standard Deviation 0.91 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01330290/results